Trading Analysis Report: ADBE

Analysis date: 2026-10-21 · Model: claude-opus-5-5 · AI-generated, not financial advice.

• Analysis date: 2026-10-21
• Rating: Hold
• Generated: 2026-10-21 13:18:59
• TradingAgents 0.6.0: anthropic, deep claude-opus-5-5, quick claude-sonnet-5-5
• Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
• Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

V. Portfolio Manager Decision

Rating: Hold

Executive Summary: Hold ADBE at $254.62. Do not add at or above $254: the probability-weighted target of $265 (about +4%) is well below a ~10% hurdle for a 1.415-beta stock whose margin and conversion drags have not turned. If you hold above standard weight, trim half the excess at $255+ now, ladder the rest at $262-267, finish the trim on a daily close below the 10 EMA (~$247), and sell any remaining excess at market a week before the print (by Dec 1 if the date stays unconfirmed). If you are flat or underweight, build at most one-third of a standard allocation, and only after the Q3 10-Q, release and call pass pre-written numeric tests: a first sixth at $243-244, a manually checked second sixth near $238 (nothing below $235), never above standard weight, one gap-exposed exit on a weekly close below $231, and sizing for a slide to $207 (stress case $190).

Current Price: 254.62

Price Target: 265.0

Confidence: Medium

Time Horizon: 3-6 months (re-rate after the Q3 10-Q read and at the mid-December Q4/FY27 print)

IV. Risk Management Team Decision

Aggressive Analyst

Aggressive Analyst: Let me open by pushing back on the idea that Hold is the timid choice here. With ADBE at 254.62, sitting under a stack of resistance from 254.98 to 257.63, Hold is the aggressive position. Aggressive means taking risk where the payoff justifies it, not buying whatever is in front of you. Buying here gives you about 11 points of upside to the 265-266 shelf against about 17 points of risk to a 2xATR stop, roughly 0.7 to 1. Nobody should take that bet on a name with a 1.4 beta. The same trade from a limit fill at 244 with a stop at 231 risks 13 to make 22, about 1.7 to 1. A fill at 241 makes it 2.5 to 1, and a fill near 235 risks about 4 points against a 30-point run back toward the September high. That is the high-reward setup, and the plan is built to get it.

I expect the conservative analyst to say this should be a trim or a sell, so let me take that on first. They will point to the margin slippage, and it's real. Operating margin was 34.8% against 36.3% a year ago, and cost of revenue grew 18.8% in Q3. But operating margin is up from 33.8% in Q2, gross margin is still near 89%, and revenue growth has accelerated from 12.0% to 12.7% to 12.9%. Operating cash flow is the cleaner read, and it grew about 15% in Q3 while the nine-month FCF margin held at 37.8% against 38.3%. A company whose growth is speeding up while it spends on AI is not obviously a broken one.

They will also say EPS growth is just buybacks, with net income up only 1% to 4%. Look at what is being bought. The stock trades at 14.2x trailing GAAP earnings with a roughly 9.4% FCF yield, and the company retires about 7% of its shares a year at that price. That is the best use of capital available to management, and it compounds if the multiple recovers at all. A return to 16x trailing EPS gets you to about 287, nearly the September high, which is hardly a heroic rerating.

On the monthly SuperTrend being down, it's a lagging regime filter that only flips after most of the recovery is done. The weekly trend is up with a stop at 206, and the stock has set a higher low at 231 against June's 193. As for the CEO's $18.3M sale at about $244 in April, it is 94% of the sale value over the year. Everything else is small, and the only priced trade in the last 90 days is a $110K sale. Meanwhile a director put $1.95M in at 194.51 near the lows. That is a mixed record, not a warning. And "business model destroyed" is hard to square with 12.9% growth and a market that has already marked the stock down to 14x.

To the neutral analyst, who I expect to argue for a balanced starter position now to avoid missing the move: ADX is 13, and the technical report itself says breakouts are unreliable in that state. In a trendless range the edge is at the bottom of the range, not the top. ATR is 8.53, so a typical day moves about as much as the pullback we want, and the 10 EMA sits at 247.16, only about 3% below. The daily z-score is 1.95, the TD count is 5, and price is pinned at the upper Bollinger band. We don't have to be right about a drop to be fine waiting. We just need the stock to wander back toward the limit orders, which it does constantly. And the next hard catalyst, probably a December 9 print though that date is unconfirmed, is about seven weeks out. Buying now means carrying a possible 7% gap with a poor entry. Waiting means arriving with a better price and cleaner information.

The trim guidance is also more aggressive than it looks. Holders above standard weight only come back to standard into 257-267 strength, so they keep their winners running while raising cash for the 241-247 orders. That is rebalancing, not capitulation.

On the 10-Q gate, the Q3 statements are already in our fundamentals pull. What's missing is debt maturities, deferred revenue, RPO, SBC and buyback detail. Those answer the real open questions: whether the 0.77 current ratio is just prepaid subscriptions, and whether the 128% FCF-to-net-income ratio holds up after SBC. That is a reading assignment that finishes well before price reaches our orders, so the gate costs nothing. I would use the reserve for 235 or below aggressively, because with a weekly-close stop at 231 the risk there is tiny against a very large reward.

I'll concede the real risks. The 78% December hike pricing comes from a roughly $1M market I wouldn't hang a thesis on, but a hawkish Fed is a genuine headwind for a 1.4-beta software name. Sentiment is thin and partly promotional, and the 10-21 bar is provisional. Those are reasons to size for the gap and honor the 231 exit, not reasons to abandon the position.

So I'd hold, keep the standing limit orders at 241-247 with a reserve below, and get aggressive only when the price pays us for it.

FINAL TRANSACTION PROPOSAL: HOLD Aggressive Analyst: Let me start by giving back what I should, because a few of my lines didn't survive your replies.

The 4-point risk at 235 is gone. The exit is a weekly close. The stock closed at 231.01 on September 28 after trading to 224.67, and a 4-point stop on an 8.5 ATR name is either noise or fiction. You're also right about the monthly SuperTrend. Its stop sits at 401, above the 52-week high of 363.70, so it can't flip in any scenario, including my 287. I called it lagging, but it's uninformative, and it should get zero weight rather than negative weight. Conservative's break-even math holds too. Thirteen over 34.6 is about 38%, and stop geometry alone doesn't create an edge. On the gate, I'll take the sequencing. Read the 10-Q before the orders go live. Pull the 10-year and VIX from somewhere other than the dead FRED feed while we're at it. I'd only ask that we write the pass/fail test down first, so the gate is a test and not a reason to never buy.

Now what survives. The 38% break-even assumes zero drift. A business with a 9.4% FCF yield and a share count falling about 7% a year isn't zero drift unless earnings roll over. Neutral saw that, and it's why the evidence should set size.

On SBC, I'll admit the 9.4% is pre-SBC. But the roughly 7% decline in diluted shares is a net figure, so it already absorbs stock issuance. Do a deliberately generous sensitivity too. If SBC took $2.5B, FCF after SBC is about $6.85B, a 6.9% yield on a $99B cap. That's right at neutral's threshold, and the filing settles it.

On margins, YoY is the right comparison, and gross margin is the real issue. But gross profit still grew about 12% YoY in Q3 on 12.9% revenue growth. The 60 bp gross margin slip is worth about $155M on trailing revenue, under 2% of FCF. The 150 bp operating margin gap is worth roughly 4%. The slope matters, and I want the filing to say whether it's compute or something else. Investing outflows were $1.9B over nine months versus $1.0B last year. If part of that is an acquisition, purchased amortization could explain some of the 18.8% cost growth. That same filing should tell us whether the revenue acceleration is organic, which cuts the other way, so I'm not cherry-picking. Revenue acceleration slowing from 0.7 points to 0.2 is still acceleration, and operating cash flow isn't lagging. It grew 14.8% in Q3. A nine-month FCF margin of 37.8% versus 38.3% is a 50 bp slip on a 38% margin. I'll live with that.

The cash figures are framed at their worst point too. Cash is down 31% from the February peak but only about 12.5% year over year. Financing outflows at 89% of operating cash flow compare with more than 100% last year. The buyback pace slowed.

Conservative's buyback point is the fairest one. Retiring shares at 14x is destructive if the disruption bears are right. But they need revenue to roll over, and revenue growth is accelerating, not slowing. The market already took 30% off the price while earnings kept growing. That's the doubt being paid for, and it's why 13 to 14x is the entry I want.

On the insider point, the CEO sold at about 244 in April, and I won't call that support. But trailing EPS then was about 17.16, back-solving from the quarters rolled off. Today it's 17.91. The same 244 buys a 13.6x business now versus 14.2x then. Same price, more earnings.

On gap risk, the June sequence is real, and the first gap wasn't the last leg. That's an argument for sizing, not for a smaller number picked by feel. Neutral's math is the cleanest in the thread. A third of standard weight at 244 carried all the way to 206 costs about 5% of a standard position. A sixth costs 2.6%. The whole sixth-versus-third debate is about 2.6 points of a standard position in a tail scenario. If the filing passes, I'd take the third.

On the reserve, I concede 231 to 235. Buying within a few points of the exit pays for a stop-out. Neutral's structure is better: main orders at 247 and 243 to 244, a small piece at 238 to 240, and a reserve at 236 to 238 that arms only if the filing passes. The whole block gets one exit, sized for slippage toward the September low. Even on that worst reading, a 235 fill has about 10 points of risk to 224.67 against about 30 to the 265 shelf, roughly 3 to 1. And conservative is right that fills down there come in a selloff, where ADX was near 32. That's what getting paid for liquidity looks like. At 235 you're buying 13.1x earnings and about a 10.2% FCF yield. The thesis there is valuation and cash flow, not trend-following. I don't want "wait for a reclaim" either, because in an ADX-13 market the reclaim signal is the same low-quality evidence we use to dismiss a breakout.

On trimming, I'd side with neutral's ladder. Today's high of 257.63 would already have filled a first rung at 256 to 258, so holders above standard weight get most of what conservative wants without selling into a provisional bar. The TD count also helps. A completed daily 9 needs the October 26 close above 256.73, which means price rises through the first rung. A rejection leaves holders with the position they chose, still at or above standard weight, which is fine.

Neutral's confirmation add is the best idea on the table. A sixth on a retest of 253 to 255 after a daily close above 257, ADX heading toward 20, OBV above -198.9 million and a clean filing keeps the plan from being a one-way bet on a deep pullback. That is aggressive in the right way. We pay up when the market proves something, not when it flatters us. Conservative's "no trend to miss at ADX 13" is also my point. With no trend, missing the move costs us nothing.

So the plan is to hold and read the filing today against a pre-written test. Put orders at 247 and 244, with a small piece at 238 to 240. Arm 236 to 238 only on a pass, with one exit for the block. Ladder sells above standard weight. Add a sixth only on a confirmed retest. Hold is the aggressive position here because we keep our capital until the price or the evidence pays for the risk.

FINAL TRANSACTION PROPOSAL: HOLD Aggressive Analyst: Let me start with what I'm giving up, because Conservative and Neutral are right on four points.

First, the confirmation add. I called it the best idea on the table, but it fails the test I opened with. A fill at 254 is about 12 points to the 266 shelf against 17 to a two-ATR stop, the same 0.7-to-1 bet I rejected at the start. It also depends on ADX and OBV in a market where I've said that evidence is weak. It's dead. If the stock runs to 290 on a takeover story without us, I'd rather miss a run I can't underwrite than pay up for it.

Second, the trim. Neutral is right that "a rejection leaves holders with the position they chose" contradicts a plan that says trim toward standard. I'll take half the excess at 255 and up, the rest on the 262 to 267 ladder, and the remainder on a daily close below the 10 EMA at 247. That is a trend-based trigger I wouldn't use to add, but the asymmetry is deliberate. A false trim costs a slice of excess, and a false add costs capital.

Third, the cap. I never proposed going past standard weight. The plan already says maintain or trim at and above standard, so Neutral is just saying it out loud. The 133% scenario was never on the table.

Fourth, the gate has to be able to fail. A 7% SBC-adjusted yield line is one nearly anything passes. I'll take Neutral's numbers: RPO growth under about 9% against 12.9% revenue growth, or organic growth more than a point below reported, means no new money until December. I'll put my thesis on that RPO number. Conservative is right that revenue lags in a subscription model, which is why RPO and deferred revenue are the leading indicators.

Now the pushback. Neutral's leakage point is the best new idea in this thread, with 77.6% of operating income reaching net income against 81.5%. But the balance sheet already says something about it. Total liabilities are up only $1.2B in a year while current liabilities rose $2.65B, so non-current liabilities fell about $1.4B. That doesn't look like a buyback funded by new borrowing. The cash drawdown over nine months, about $1.1B, also looks like the funding source. So my read is that the borrowing test passes and the debt-maturity question is about timing, not stress. The leakage is more likely tax or lower interest income, and the footnotes will say. I haven't proven that. But two of Conservative's five tests already lean toward a pass before we open the filing, which is what a real gate looks like.

On "a clean filing isn't an edge because the market has seen it," look at the closes: 266.51 on September 4 and 265.60 on September 14, with the heavy-volume days in between. If those were the print, it left no net mark on the price, and the slide to 231 came in the two weeks after. So the low probably wasn't the market reacting to the reported numbers. Either it reacted to something on the call, which is why Neutral's addition of the release and call matters, or it was sector and AI-fear tape. In that case the rebound is the same tape in reverse. We should know which before we buy the second sixth.

That leads to the fight I still want. If a pass can only ever buy a sixth, the gate is a veto with no upside. A sixth bought at 244 and carried to 287 adds about 3% to a standard position. We'd be building a reading list, a checklist and an exit rule to move the account by a rounding error in either direction. Neutral's structure fixes that: evidence earns the first sixth and price earns the second.

I'll take alerts at 241 and 238 instead of resting orders. Distance from the exit is a fair concern. But the checklist needs a written default, or it turns into a debate at the worst moment. Check the 10-year and VIX, then ask whether the drop is about Adobe or about the sector. If it's sector-wide with a clean filing, buy the sixth. If it's Adobe-specific, such as a guidance leak, an executive exit or a lost AI position, don't. Sector moves don't change Adobe's cash flows and company moves do. Conservative says the bounce is sector beta with no Adobe news. I agree, and that's why this rule works.

Conservative's point that liquidity providers get paid only when the seller is uninformed describes a market maker. We aren't earning a spread. At 238 we're buying 13.3x earnings and about a 10% FCF yield with a shared exit, and the checklist screens for the informed seller. Also, FRED is down. Whoever owns the checklist needs a working source for the 10-year and VIX today, or it's a wish.

On valuation, 13x isn't a floor. The market paid 10.6x in June and the CEO sold at 14.2x. I don't need a floor, I need to size for its absence, which is why I'm using 207 as the base case and 190 as the stress. At the 52-week high the stock was about 20 times today's trailing EPS. It's 14.2 now with higher EPS, revenue growth went from 10.7% to 12.9%, and RPO will tell us whether that growth is durable.

So Hold. Do the reading today against written numbers, including the release and call. On a fail, no new money, and holders above standard trim as above. On a pass, rest the first sixth at 247 and 243 to 244, with alerts at 241 and 238 for a live-checked second sixth. Cap the total at standard weight, with one exit on a weekly close below 231, treated as gap-exposed. Buy nothing above 254, and make no other adds before December guidance.

FINAL TRANSACTION PROPOSAL: HOLD Aggressive Analyst: Let me start with what you've earned, since you're right on most of the specifics.

Conservative, the balance sheet read. Neutral's arithmetic settles it for me. A debt-to-equity of 0.58 on $11.76B of equity implies about $6.8B of debt, and total non-current liabilities are only $6.33B, a bucket that also holds long-term deferred revenue, tax and leases. So some of that debt is probably already in current liabilities. I withdraw "two of five tests lean pass." It's a number to read. I'd only add the scale: even if notes are coming due, that's a refinancing or paydown against $9.35B of free cash flow and $4.4B of cash. It belongs on the checklist, not the worry list.

You're also right that lower interest income can't explain the leakage. $0.6B less cash is single-digit millions a quarter, not $90M.

I accept the thresholds. An RPO growth rate near 11% against 12.9% revenue growth is a pass, under 9% is a hard fail, and the zone between is no new money. An unexplained 18.8% jump in cost of revenue is also no new money. In a name whose bear case is margins, an open question should block the buy. The 10-year and VIX source and a confirmed earnings date come first. The FRED outage is a tool problem, and fixing both takes minutes.

The 247 buy is gone. My own opening math says why. From 247 to the 231 exit is 16 points of risk for about 19 to the 265 shelf, roughly 1.2 to 1. At 243.5 it's about 12.5 for 22. The first sixth goes at 243 to 244 and nothing higher. I also accept cancelling resting orders about a week before the print once the date is confirmed.

Now where I won't move. On leakage, you said three straight quarters doesn't look like a one-off. I agree, but that makes it a step, not a drain. The gap between net income and operating income conversion was about 5.6 points in Q1, 3.7 in Q2 and 3.9 in Q3. It isn't widening. A tax-rate step that began around the start of fiscal 2026 laps in Q1 FY27, and net income growth then converges toward operating income growth. Interest on borrowed buyback money wouldn't lap. That's why the effective tax rate by quarter, and whether the gap carries into FY27, goes on the reading list. I'm not claiming it's benign, only that the data doesn't show it growing.

Next, the second-sixth default. Requiring a market-wide drop with the index down, VIX up and no AI headline attached describes a tape that almost never appears in a year when software has traded on AI fear. We've spent three rounds unable to say whether September's 21% slide was the call, the tape or AI fear, and we have weeks of hindsight. A rule that demands clean real-time classification and defaults to no will say no every time. So I side with Neutral. The test is whether anything changed in cash flows or estimates, not whether the letters AI show up in a headline. A named AI substitution story, a competitor release, a customer loss, a guidance leak or estimate cuts is a no. Conservative gets a real veto, with the burden on identifying a specific Adobe negative. If the cause is still unclear after the next session, the answer is also no. And I'll take Neutral's rule of not acting on the alert bar itself. Run the checklist and buy the next session if it still reads clean. That is the human decision in front of the fill that answers the short-put worry, and I'll pay for the bounces it costs.

On "stakes this small argue for a simpler process," Neutral's reframe is the best idea in the last round. A sixth moves the account by about 3% either way, but a standard holding carries seven or eight times that. Dropping to 207 is about 19% of the whole position and 190 is about 25%. The filing read mostly informs the core, not the starter. And nobody had written down what happens to the core. I accept the answer. The new block exits on a weekly close below 231, treated as gap-exposed. The core isn't auto-sold, since at 231 it's about 13x trailing earnings with a free cash flow yield over 10%. But that close forces a written re-underwrite within the week. If the gate failed or the cause is Adobe-specific, the default is a one-third trim. If the gate passed and the cause is macro or sector, the default is hold. A severe fail, meaning RPO under 9% with cost of revenue unexplained, reopens whether standard weight is right at all. I'd add the mirror image. A clean pass gets written down as the reason to hold the core through ordinary noise, so we don't re-argue it mid-drawdown.

The case for Hold as the aggressive choice is this. We won't pay for risk at 254, under a stack of resistance with ADX at 13, an unread filing, and a December hike market we can't verify. But every branch has to do something. A pass buys the first sixth on a 4% dip, and price plus a clean checklist can earn the second at 241 or 238, never within a few points of the exit. Guidance in December is where the real size decision happens. A plan where the gate can fail but a pass never acts isn't caution, it's abstention. If ADBE runs to 290 on a takeover story without us, I'm at peace with that. I can't underwrite that run, and I can underwrite 13x earnings with a 10% free cash flow yield at 238.

So here is the plan. Set the numeric pass/fail tests first. Confirm the rate and VIX sources and the earnings date. Read the 10-Q, the release and the call today. On a fail, no new money, and holders above standard weight trim as agreed. On a pass, rest the first sixth at 243 to 244 and set alerts at 241 and 238 for a next-session, checklist-cleared second sixth. Total exposure is capped at standard weight. Size the new block for a slip to 207 and stress it at 190. Buy nothing above 254, and make no other adds before December guidance. Holders above standard weight trim half the excess at 255 and up, ladder the rest at 262 to 267, and finish the trim on a daily close below the 10 EMA.

FINAL TRANSACTION PROPOSAL: HOLD Aggressive Analyst: Let me start with what I'm taking, because most of the last round improved the plan.

The pre-print rule is the best addition. Any excess above standard weight goes to standard at market a week before a confirmed date, with December 1 as the placeholder. It's the one trim that doesn't need price to cooperate, and it's risk control on size we chose to hold, not capitulation. I also accept counting the block as a full third from the first fill. I was calling a 241 alert "price earning the second sixth" when 241 is 0.35 ATR below the first fill, which is one ordinary day. Keep 238 with Neutral's 235 floor and two clean sessions. It will rarely fill, and I'm fine with that.

I'm taking Neutral's version of the peer test over a flat "point or two," since a band that tight trips on noise. I'd apply the same method to rates and VIX. Define the thresholds as percentiles of the trailing year, written down before looking. That answers Conservative's calibration problem without anyone needing a view while FRED is down. On the core, I'll take the one-third trim when the cause is unclear, with Neutral's way back at classification or December guidance. From 231, a third of the core is about 3.5% of the position avoided if the stock reaches 207, and about 6% at 190. A rebound to 254 forgoes about 3.3%. The payoffs are roughly symmetric, and the tail is protected.

On valuation, you're right and I'll fix my line. The 10% yield at 238 was pre-SBC. The honest cross-check is that 238 is 13.3x GAAP earnings, which are already after stock comp, an earnings yield around 7.5%. Conservative's generous SBC case puts the FCF yield at 7.4%. Two different measures land in the same place, so 7.5% is the number I'll use. I also won't argue the 16x rerating anymore. If net income converges to operating income growth of 6% to 8%, add the roughly 7% share shrink and EPS growth is 13% to 15% at 14.2x trailing. That's a PEG near 1, which is reasonable but not the 0.59 on the screen.

Conservative is also right that I overstated "every branch has to do something." What I meant is that every branch needs a written action, and "no new money" is a written action. What I won't accept is a pass branch that can't buy anything.

Now, three places where I still think the plan leans too far toward comfort.

First, June cuts both ways. Conservative cites 218.80, then 204.02, then 190.12 intraday to show that a weekly-close exit protects nothing. True. But look at what the rule would have done. If the prior weekly close was above 231, which I haven't checked, it fires on Friday June 12 at about 204. The most it could have saved was the last 7% down to 190. The stock then closed at 193 on June 25 and at 292.79 on August 31, a rise of roughly 43% from where the exit would have sold. That is hindsight, and it won't repeat on schedule. But it's why the exit belongs on the new block only, why the core gets a re-underwrite instead of an auto-sale, and why the way back matters. The real gap protection is sizing and the pre-print rules, not the stop.

Second, the plan has a ratchet. Before the print we cancel buys, trim the excess and carry only standard weight. Nothing says what re-risks us afterward. If the second sixth only fills on a drop to 238 with a clean checklist, it mostly won't fill. So write the upside branch now. In December, guidance decides, not price. If RPO is near 11% or better, the margin guide is stable and cost of revenue has an explanation, then the second sixth and any trimmed third come back up to standard, even if the stock is above 254. That's evidence paying, not price chasing, and it's the one place I'd pay up. It's also why a 4% better entry is worth waiting for. The research plan underwrites roughly 10% at a constant multiple, and buying near 243.5 instead of 254.62 adds four to five points to that.

Third, the gate list has to close. We now have the 10-Q, release and call, rate and VIX sources with percentile rules, a confirmed date, and a price pull for the peer distribution. That's an afternoon of work. Time-box it, and don't add gates mid-drawdown, which is how a disciplined plan turns into an excuse. I'd also make "open" checkable. If the filing is silent on a named number, like RPO or the effective tax rate, that's open and means no. If it merely feels murky, it isn't a veto.

The plan, then. Write the numeric tests first: RPO near 11% to pass, under 9% to fail, anything between means no new money. The cost-of-revenue explanation, effective tax rate and whether it persists, debt maturities and borrowing, and organic growth within a point of reported also get tested. Confirm the data sources and the date, then read the 10-Q, release and call. A fail or a named open item means no new money. A pass rests the first sixth at 243 to 244, cancelled by December 1 or a week before the confirmed date. The 238 alert runs with the 235 floor, next-session execution, the relative-move and percentile tests, two clean sessions and no named Adobe negative. Total exposure is capped at standard, with one gap-exposed exit on a weekly close below 231, sized for 207 and stressed at 190. The core holds through the print, with a written re-underwrite on that close and a third off if the cause is unclear. Holders above standard take half the excess at 255 and up, the rest at 262 to 267, finish on a daily close below the 10 EMA, and sell whatever remains at market a week before the print. Buy nothing above 254, and make no technical adds.

That is Hold as the aggressive choice: patient where price doesn't pay us, and willing to pay up when December proves something.

FINAL TRANSACTION PROPOSAL: HOLD